BTC $71,807
2026 Bull Run Is Building Start trading with 5% OFF all fees
Sign Up Now
BTC $71,807
Bull Run 2026 | 5% Off Fees Open your Binance account today
Sign Up

Nvidia Gains After $20B Groq Licensing Deal for Inference AI

Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell

  • Stocks rose midday Friday as U.S. markets reopened after the Christmas holiday, with the S&P 500 hitting a fresh high.
  • NVIDIA agreed to a non‑exclusive licensing deal for its inference technology valued at about $20 billion, lifting its shares nearly 2%.
  • Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell all saw notable gains after company‑specific news.

U.S. equities traded higher midday Friday as investors returned after the Christmas holiday and the S&P 500 notched a new all‑time high. Markets showed modest ETF gains: the SPDR S&P 500 ETF (SPY) rose 0.08%, the Invesco QQQ Trust (QQQ) gained 0.16%, and the SPDR Dow Jones Industrial Average ETF Trust (DIA) climbed 0.01%.

- Advertisement -

Nvidia Corp. shares rose nearly 2% after the company entered a non‑exclusive licensing agreement with Groq for its inference technology, a deal valued at about $20 billion. Inference technology is software and models that run trained artificial‑intelligence systems to produce outputs from input data.

Sidus Space Inc. jumped more than 22% midday after the firm was awarded a contract under the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) program. SIDU stock has climbed about 237% over the past five trading sessions.

According to Reuters, Coupang Inc. rose over 9% after the company said that “all leaked customer information has been deleted”; Coupang stated the suspect was a former employee. CPNG is up roughly 10% over the past five trading sessions.

Vanda Pharmaceuticals Inc. gained nearly 8% in premarket trading before settling about 3% higher as investors awaited an upcoming U.S. Food and Drug Administration decision on Tradipitant, a motion‑sickness prevention drug. VNDA is up 7% over five sessions.

- Advertisement -

ImmuCell Corp. rose nearly 10% midday after announcing a 50% expansion of its First Defense field sales force and plans to scale up drug manufacturing; the company also said it is pausing its Re‑Tain treatment for cows after receiving an “Incomplete Letter” from the FDA. ICCC is up about 2% over the past five trading sessions.

✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.

Previous Articles:

- Advertisement -
Ad
Altseason Is Loading. Don't watch from the sidelines.
SOL $90.51
DOGE $0.0963
LINK $9.02
SUI $1.00
5% off fees when you sign up
Start Trading
Ad
Pay Less on Every Trade. For Life.
$10K/mo volume Save $60/yr
$50K/mo volume Save $300/yr
$100K/mo volume Save $600/yr
5% off all trading fees when you sign up
Claim Your Discount

Latest News

Bitcoin Surges Past $79,500, Highest Since May

Bitcoin climbed to $79,500 on August 21, its highest since May, fueled by a...

Bitget CEO predicts Bitcoin will stay near $70k through year-end

Bitget CEO Gracy Chen expects Bitcoin to remain near current levels through year-end, citing...

Anthropic to file IPO this month, targets SpaceX record

Anthropic will reportedly file its IPO on the US stock market before the end...

Trump, CFTC chair warn of crypto crackdown if Clarity stalls

Trump hosted crypto executives at the White House and urged Congress to pass a...

Nvidia’s AI Ecosystem Support Key to Upside, BMO Says

NVIDIA is expanding beyond GPU sales into AI infrastructure investments and partnerships.BMO Capital initiated...

Must Read

TOP 12 Day Trading Crypto Books For Beginners

Day trading cryptocurrencies has become an increasingly popular financial activity, offering the potential for huge returns to those who understand the market's complexities and...
Ad
Altseason Is Loading. These 4 coins are trending right now.
SOL $92.12
DOGE $0.0950
LINK $9.02
SUI $1.02
5% off spot fees when you sign up
Start Trading